Mandate

Vinge advises Oberthur Technologies in public offer for XPonCard

February 27, 2008

Vinge is advising Oberthur Technologies in connection with its announced public offer for XPonCard Group AB (publ). The offer, which comprises all shares in XPonCard, values XPonCard at approximately SEK 704 million.

The Vinge team advising Oberthur Technologies S.A. includes Anders Åberg, Jan Lombach, Mattias Friberg and Petter Elmstedt. Paula Röttorp, Louise Salomon and Anders Morén are providing advice regarding the financing, and Mattias Schömer and Johan Bocander are providing tax advice. Emma Dufva is providing competition law advice.

Oberthur Technologies is listed on Euronext Paris. Oberthur Technologies is one of the world leaders in the field of secure technologies in its main target markets: smart cards, secure printing and cash protection. XPonCard is a services company listed on OMX Nordic Exchange Stockholm that provides card concepts and solutions for secure payment, smart mobile solutions, improved customer loyalty and secure identification. The combination of Oberthur Technologies and XPonCard will create the second largest player in the global smart card industry with sales in the order of EUR 735 million (SEK 6.8 billion).

Related

Vinge advises the sellers of Berg Propulsion

Vinge has advised the sellers in connection with the sale of Berg Propulsion to Kongsberg Maritime.
September 10, 2026

Naval Group signs contract for four defence and intervention frigates (FDI) for the Royal Swedish Navy

Vinge has advised Naval Group in connection with the negotiations with the Swedish Defence Materiel Administration (FMV) for the procurement of four defence and intervention frigates (FDI) for the Swedish Navy. The contract was signed on 31 August 2026 in Stockholm. Naval Group has been selected as a strategic partner by the Swedish Government to rapidly strengthen and modernise its fleet's capabilities.
September 08, 2026

Vinge advises Axcel and Sanviva on the acquisitions of DermaCura and YourRad

Vinge has advised Axcel Elevate I and Sanviva in connection with the acquisitions of DermaCura and YourRad.
September 07, 2026